Auna S.A. - Cls A

Research Auna S.A. - Cls A (AUNA) on Bullrun: valuation model: 4.5% overvalued, market cap USD 390.79M, P/E 21.9. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Valuation Snapshot

Bullrun's latest valuation model marks Auna S.A. - Cls A as 4.5% overvalued; latest market cap is USD 390.79M; P/E is 21.9.

Peer valuation comparison

Latest P/E is 21.85x versus a Healthcare sector median of 24.46x (10.7% below).

Latest P/E is 21.85x versus a Luxembourg median of 15.74x (38.9% above).

Five-year financial history

YearRevenueNet incomeFree cash flowGross marginDiluted EPSCashTotal debtEquity
FY2025PEN 4.38BPEN 97.02MPEN 517.82M37.9%1.31PEN 335.44MPEN 3.66BPEN 1.60B
FY2024PEN 4.39BPEN 110.27MPEN 526.59M39.3%1.39PEN 235.75MPEN 3.77BPEN 1.48B
FY2023n/an/an/an/a-4.02PEN 241.13MPEN 3.92BPEN 1.47B

Valuation history

YearSnapshot dateMarket capP/EDividend yieldAnnual dividend/share
20262026-08-25USD 390.79M21.9n/an/a
20252025-12-31USD 364.14Mn/an/an/a
20242024-12-31USD 507.44M19.1n/an/a

About Auna S.A. - Cls A

Auna S.A., a healthcare service provider, operates hospitals and clinics in Mexico, Peru, and Colombia. The company provides prepaid healthcare; dental and vision insurance; and oncology plans. It also sells medicines. Auna S.A. was founded in 1989 and is based in Luxembourg, Luxembourg.

Related stock research

Other Healthcare stocks

Frequently asked questions

Is Auna S.A. - Cls A overvalued or undervalued?

Bullrun's valuation model currently marks Auna S.A. - Cls A as 4.5% overvalued.

What is Auna S.A. - Cls A's market cap?

Auna S.A. - Cls A's market capitalization is USD 390.79M.

What is Auna S.A. - Cls A's P/E ratio?

Auna S.A. - Cls A's price-to-earnings (P/E) ratio is 21.9.

What does Auna S.A. - Cls A do?

Auna S.A., a healthcare service provider, operates hospitals and clinics in Mexico, Peru, and Colombia. The company provides prepaid healthcare; dental and vision insurance; and oncology plans. It also sells medicines. Auna S.A. was founded in 1989 and is based in Luxembourg, Luxembourg.